TWIN STUDY
Study shows less risk of harm by alcohol in states with legal cannabis
Marijuana Moment reports that researchers have found that those living in states where cannabis had been legalised were “less likely to risk harm while under the influence of alcohol” than their twin residing in a state where cannabis remained prohibited.
Additionally, the researchers speculate that their results did not find any link between cannabis legalisation and an increase in psychosocial disorders.
The team at the University of Colorado and University of Minnesota wrote: “Recreational legalisation was associated with increased cannabis use and decreased AUD symptoms but was not associated with other maladaptations. We established evidence that suggests cannabis legalization causes a 0.11 standard deviation increase in cannabis frequency, whereas AUD symptoms decreased by 0.11 standard deviations driven by reductions in use of alcohol when physically hazardous.”
MOLD TESTING
Cannabis testing methods need more data for confidence
Pat Bird, senior manager of scientific affairs at bioMérieux, writes for MJ Biz Daily on cannabis testing methods.
Bird highlights that as demand for cannabis continues to trend upward, there’s been an increase of product cultivation to meet this growing demand, resulting in a correlating uptick in the volume of microbiology testing required to ensure product can be released into the market.
“Confidence in diagnostic testing is best achieved when there is a true collaboration between the method developer and their testing partner.
“No method developer expects labs to understand everything about testing on their own.”
EU STOCK REVIEW
Khiron spikes on Colombian insurance deal, Apollon divests patents, & more from Seach Medical
BusinessCann provides the latest roundup of European cannabis industry stocks.
At the end of last year the UN General Assembly made history by adopting a resolution on drugs that did not include a long-standing reference to ‘actively promoting a society free of drug abuse’.
In Germany, however, the 200-year old German Customs and Finance Union has voiced its opposition to its Government’s plans to legalise cannabis in the country.
Chairman Dieter Dewes stated: “A national solo attempt to legalise a product that continues to be prohibited under Union law would be completely contrary to the system, if only with a view to the cross-border movement of goods in the internal market.”
This has not deterred business however, and the publication notes that US CBD and cannabis manufacturer Ambari Brands – backed by Kim Kardashian – has been listed in one of Europe’s largest retailers El Corte Ingles, as well as expanding its on-line European presence.
